New search Show text from Guidelines
J ANTIINFECTIVES FOR SYSTEMIC USEJ05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AP Antivirals for treatment of HCV infections
ATC code | Name | DDD | U | Adm.R | Note |
J05AP01 | ribavirin | 6 | g | Inhal.solution | |
1 | g | O | |||
J05AP02 | telaprevir | 2.25 | g | O | |
J05AP03 | boceprevir | 2.4 | g | O | |
J05AP04 | faldaprevir | ||||
J05AP05 | simeprevir | 0.15 | g | O | |
J05AP06 | asunaprevir | 0.2 | g | O | |
J05AP07 | daclatasvir | 60 | mg | O | |
J05AP08 | sofosbuvir | 0.4 | g | O | |
J05AP09 | dasabuvir | 0.5 | g | O | |
J05AP10 | elbasvir | 50 | mg | O | |
J05AP11 | grazoprevir | 0.1 | g | O | |
J05AP12 | coblopasvir | ||||
J05AP13 | ravidasvir | 0.2 | g | O | |
J05AP51 | sofosbuvir and ledipasvir | ||||
J05AP52 | dasabuvir, ombitasvir, paritaprevir and ritonavir | ||||
J05AP53 | ombitasvir, paritaprevir and ritonavir | ||||
J05AP54 | elbasvir and grazoprevir | ||||
J05AP55 | sofosbuvir and velpatasvir | ||||
J05AP56 | sofosbuvir, velpatasvir and voxilaprevir | ||||
J05AP57 | glecaprevir and pibrentasvir | ||||
J05AP58 | daclatasvir, asunaprevir and beclabuvir |
Last updated: 2024-01-26